CONMED (CNMD) interim finance chief reports initial stock and option holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
CONMED Corp reported initial holdings for Kimberly Lockwood, Interim Corporate Controller and Principal Financial Officer. The Form 3 shows direct ownership of 1,868 shares of common stock and multiple equity awards granted under the company’s long-term incentive plans.
Lockwood holds RSUs covering 2,838 and 2,839 underlying shares of common stock, which generally vest over three years under the 2025 Long-Term Incentive Plan. She also holds several option grants on common stock, with exercise prices ranging from $58.33 to $144.55 per share and expiration dates between 2028 and 2035, typically vesting in equal installments over five years.
Positive
- None.
Negative
- None.
Insider Trade Summary
11 transactions reported
Mixed
11 txns
Insider
Lockwood Kimberly
Role
Interim Corp Controller & PFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options To Purchase Common Stock | -- | -- | -- |
| holding | Options To Purchase Common Stock | -- | -- | -- |
| holding | Options To Purchase Common Stock | -- | -- | -- |
| holding | Options To Purchase Common Stock | -- | -- | -- |
| holding | Options To Purchase Common Stock | -- | -- | -- |
| holding | Options To Purchase Common Stock | -- | -- | -- |
| holding | Options To Purchase Common Stock | -- | -- | -- |
| holding | Options To Purchase Common Stock | -- | -- | -- |
| holding | RSUs (Restricted Stock Units) | -- | -- | -- |
| holding | RSUs (Restricted Stock Units) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Options To Purchase Common Stock — 1,400 shares (Direct, null);
RSUs (Restricted Stock Units) — 2,839 shares (Direct, null);
Common Stock — 1,868 shares (Direct, null)
Footnotes (1)
- The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.
Key Figures
Direct common shares: 1,868 shares
RSUs grant 1: 2,838 shares
RSUs grant 2: 2,839 shares
+4 more
7 metrics
Direct common shares
1,868 shares
Directly owned CONMED common stock reported on Form 3
RSUs grant 1
2,838 shares
Underlying CONMED common shares from RSUs expiring 2036-05-11
RSUs grant 2
2,839 shares
Underlying CONMED common shares from RSUs expiring 2036-03-02
Options at $58.33
4,500 shares
Stock options with $58.33 exercise price expiring 2035-03-03
Options at $79.95
2,500 shares
Stock options with $79.95 exercise price expiring 2034-03-01
Options at $144.55
2,750 shares
Stock options with $144.55 exercise price expiring 2032-03-01
Options at $59.96
1,400 shares
Stock options with $59.96 exercise price expiring 2028-03-01
Key Terms
Restricted Stock Units, Long-Term Incentive Plan, par value, stock options
4 terms
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Long-Term Incentive Plan financial
"under the Company's 2015 Amended and Restated Long-Term Incentive Plan and 2018 Long-Term Incentive Plan"
A long-term incentive plan is a company program that pays executives or employees with stock, options, or cash tied to multi-year performance goals, where the rewards become theirs only after meeting conditions over time. Think of it as a delayed bonus or retirement-style reward that aligns employees’ interests with shareholders by encouraging them to boost long-term value; investors watch these plans because they affect pay costs, share dilution and management incentives.
par value financial
"one share of common stock, par value $0.01 per share of CONMED Corporation"
Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.
stock options financial
"The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
FAQ
What does Kimberly Lockwood’s Form 3 for CONMED Corp (CNMD) disclose?
The Form 3 discloses Kimberly Lockwood’s initial ownership in CONMED. It reports 1,868 directly held common shares plus multiple restricted stock units and stock options granted under company long-term incentive plans, outlining her existing equity-based compensation position at the time of reporting.
What restricted stock units are reported for Kimberly Lockwood in CONMED’s Form 3?
The filing reports two RSU positions representing 2,838 and 2,839 underlying CONMED common shares. Each RSU equals one share upon vesting and is subject to the 2025 Long-Term Incentive Plan, generally vesting over three years in 33%, 33%, and 34% annual tranches.
What stock options does Kimberly Lockwood hold in CONMED (CNMD)?
Lockwood holds several options to purchase CONMED common stock, including 4,500 shares at $58.33 and 2,500 at $79.95 per share. Additional option grants span exercise prices up to $144.55, generally vesting over five years and expiring between 2028 and 2035.
Under which incentive plans were Kimberly Lockwood’s CONMED equity awards granted?
The stock options were granted under CONMED’s 2015 Amended and Restated Long-Term Incentive Plan and its 2018 Long-Term Incentive Plan. The RSUs are subject to the 2025 Long-Term Incentive Plan, with each plan defining vesting schedules and other award conditions.